Editorial
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that?
Perspective
Research Highlight
Commentary
Correspondence
Disclosure:
This supplement was published without any sponsorship or funding.
![](http://cdn.amegroups.cn/journals/pbpc/public/journals/3/cover_issue_196_en_US.png/w800)